Home - Mirum Pharma
mirumpharma.comMirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022 Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index
Actelion - Wikipedia
https://en.wikipedia.org/wiki/ActelionActelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases.Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart …
Basil Pharmaceuticals
https://www.basilpharmaceutical.comBasil Pharmaceuticals functional expertise with in-depth knowledge of API manufacturing and excellent relationships in the Indian pharmaceutical market place. Helping pharmaceutical companies to grow their businesses in new and existing markets, our success is based on utilizing our sourcing, production and marketing ability to optimally meet the needs of our …
Basil Pharmaceuticals
www.basilpharmaceutical.comBasil Pharmaceuticals functional expertise with in-depth knowledge of API manufacturing and excellent relationships in the Indian pharmaceutical market place. Helping pharmaceutical companies to grow their businesses in new and existing markets, our success is based on utilizing our sourcing, production and marketing ability to optimally meet ...
Basilea.com : Basilea
https://basilea.com/CareersBasilea is headquartered in Basel, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). CEO David Veitch | Half-year 2021 Update. Play. News. Jan 13. 2022 Basilea announces approval of antifungal Cresemba® (isavuconazole) for invasive aspergillosis in China Weiterlesen ...
Home - Mirum Pharma
https://mirumpharma.comMirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones Mirum Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022 Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index